V

Vaxart
D

VXRT

0.59900
USD
-0.01
(-1.53%)
Market Closed
Volume
8,347
EPS
-0
Div Yield
-
P/E
-1
Market Cap
136,236,137
OverviewSignalsIdeasNews
Related Instruments
    A
    APDN
    -0.01260
    (-7.25%)
    0.16110 USD
    AZN
    AZN
    -1.830
    (-2.81%)
    64.255 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    C
    CODX
    -0.04000
    (-3.64%)
    1.06000 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.14 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    V
    VIR
    -0.63500
    (-7.35%)
    8.01000 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.37 USD
    More
News

Title: Vaxart

Sector: Healthcare
Industry: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.